Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1B |
| 2 |
Netflix
NFLX
|
+$721M |
| 3 |
Apple
AAPL
|
+$468M |
| 4 |
UnitedHealth
UNH
|
+$422M |
| 5 |
GE Vernova
GEV
|
+$376M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$673M |
| 2 |
Robinhood
HOOD
|
+$481M |
| 3 |
Meta Platforms (Facebook)
META
|
+$433M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$402M |
| 5 |
Palantir
PLTR
|
+$380M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Cytokinetics
CYTK
$6.22B
| $336K | ﹤0.01% |
10,167
-110,500
| -92% | -$3.65M |
|
3002
AMC Networks
AMCX
$328M
| $335K | ﹤0.01% |
+53,500
| New | +$335K |
|
3003
Tango Therapeutics
TNGX
$708M
| $335K | ﹤0.01% |
65,500
-109,000
| -62% | -$558K |
|
3004
Dream Finders Homes
DFH
$2.7B
| $334K | ﹤0.01% |
13,300
-96,310
| -88% | -$2.42M |
|
3005
IRIDEX
IRIX
$22.4M
| $334K | ﹤0.01% |
378,760
-400
| -0.1% | -$353 |
|
3006
Quest Resource Holding
QRHC
$35.8M
| $333K | ﹤0.01% |
165,092
-16,900
| -9% | -$34.1K |
|
3007
Ostin Technology Group
OST
$10M
| $333K | ﹤0.01% |
+84,192
| New | +$333K |
|
|
ALTS
3008
ALT5 Sigma Corporation Common Stock
ALTS
$490M
| $333K | ﹤0.01% |
45,900
-46,267
| -50% | -$335K |
|
3009
RenovoRx
RNXT
$42.9M
| $331K | ﹤0.01% |
251,800
+224,144
| +810% | +$295K |
|
3010
i3 Verticals
IIIV
$720M
| $330K | ﹤0.01% |
12,000
-8,300
| -41% | -$228K |
|
3011
United Homes Group
UHG
$249M
| $329K | ﹤0.01% |
+113,500
| New | +$329K |
|
3012
WisdomTree India Earnings Fund ETF
EPI
$2.93B
| $328K | ﹤0.01% |
+6,900
| New | +$328K |
|
|
OTLY
3013
Oatly Group
OTLY
$513M
| $327K | ﹤0.01% |
27,549
-3,129
| -10% | -$37.1K |
|
3014
MEI Pharma
MEIP
$101M
| $327K | ﹤0.01% |
132,346
-2,100
| -2% | -$5.19K |
|
3015
Clearwater Analytics
CWAN
$5.88B
| $327K | ﹤0.01% |
14,899
-1,344,201
| -99% | -$29.5M |
|
3016
Forward Industries
FORD
$43.3M
| $325K | ﹤0.01% |
55,593
+3,901
| +8% | +$22.8K |
|
3017
Oramed Pharmaceuticals
ORMP
$95.5M
| $324K | ﹤0.01% |
144,200
+1,700
| +1% | +$3.83K |
|
|
NEWP
3018
New Pacific Metals
NEWP
$363M
| $323K | ﹤0.01% |
241,314
-91,511
| -27% | -$123K |
|
3019
Nuvectis Pharma
NVCT
$160M
| $321K | ﹤0.01% |
+43,000
| New | +$321K |
|
3020
MDxHealth
MDXH
$172M
| $321K | ﹤0.01% |
145,273
+23,073
| +19% | +$51K |
|
|
AHT
3021
Ashford Hospitality Trust
AHT
$38M
| $320K | ﹤0.01% |
53,103
+1,100
| +2% | +$6.62K |
|
3022
NeuroOne Medical Technologies
NMTC
$44.4M
| $318K | ﹤0.01% |
+468,900
| New | +$318K |
|
3023
Dimensional International Core Equity Market ETF
DFAI
$11.4B
| $318K | ﹤0.01% |
+9,200
| New | +$318K |
|
3024
Traeger
COOK
$178M
| $318K | ﹤0.01% |
185,900
+32,322
| +21% | +$55.3K |
|
3025
iShares 20+ Year Treasury Bond ETF
TLT
$49.5B
| $318K | ﹤0.01% |
3,600
-89,686
| -96% | -$7.91M |
|